You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


FDA approves Ironwood’s irritable bowel drug

Ironwood Pharmaceuticals Inc. says it is on track to start selling a treatment for chronic constipation and irritable bowel syndrome in adults, following Thursday’s approval by the Food and Drug Adminstration.

The highly anticipated pill, called Linzess, will be the first product developed by the 14-year-old Cambridge company to hit the market. The FDA approval was expected, but most observers had predicted it would come next month.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week